Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.73B |
| 2 |
NewMarket
NEU
|
+$67.2M |
| 3 |
Gen Digital
GEN
|
+$66.9M |
| 4 |
General Mills
GIS
|
+$63.7M |
| 5 |
Humana
HUM
|
+$63M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Western Digital
WDC
|
+$97.7M |
| 2 |
Micron Technology
MU
|
+$88M |
| 3 |
MASI
Masimo
MASI
|
+$60.7M |
| 4 |
SNDK
Sandisk
SNDK
|
+$55.1M |
| 5 |
Crown Holdings
CCK
|
+$46.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.32% |
| 2 | Industrials | 11.66% |
| 3 | Consumer Discretionary | 9.38% |
| 4 | Healthcare | 7.34% |
| 5 | Financials | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
NEOS Nasdaq 100 High Income ETF
QQQI
$13.8B
| $9.68M | 0.02% |
170,523
+97,673
| +134% | +$5.37M |
|
802
Ionis Pharmaceuticals
IONS
$9.93B
| $9.61M | 0.02% |
121,252
+22,284
| +23% | +$1.68M |
|
803
BrightSpring Health Services
BTSG
$11.6B
| $9.6M | 0.02% |
+137,718
| New | +$7.65M |
|
804
Flutter Entertainment
FLUT
$17.8B
| $9.6M | 0.02% |
94,003
+56,111
| +148% | +$5.78M |
|
805
NiSource
NI
$19.5B
| $9.57M | 0.02% |
+201,222
| New | +$9.52M |
|
806
Americold
COLD
$4.35B
| $9.55M | 0.02% |
607,817
-85,819
| -12% | -$1.18M |
|
807
Okta
OKTA
$23.5B
| $9.52M | 0.02% |
69,754
-55,314
| -44% | -$5.2M |
|
808
Interactive Brokers
IBKR
$42.5B
| $9.52M | 0.02% |
109,329
-5,493
| -5% | -$457K |
|
809
Morgan Stanley
MS
$336B
| $9.48M | 0.02% |
45,373
+139
| +0.3% | +$27.5K |
|
810
Vanguard Morningstar Mid-Cap ETF
VO
$109B
| $9.48M | 0.02% |
117,712
| – | – |
|
811
Caesars Entertainment
CZR
$6.06B
| $9.48M | 0.02% |
313,990
+97,167
| +45% | +$2.74M |
|
812
iShares S&P 500 Growth ETF
IVW
$75.9B
| $9.45M | 0.02% |
68,716
+12,300
| +22% | +$1.62M |
|
813
Vertex Pharmaceuticals
VRTX
$139B
| $9.43M | 0.02% |
18,986
-1,901
| -9% | -$842K |
|
814
Stepan Co
SCL
$1.45B
| $9.39M | 0.02% |
168,599
+94
| +0.1% | +$4.89K |
|
815
Fidelity Enhanced Large Cap Core ETF
FELC
$8.45B
| $9.3M | 0.02% |
221,851
+161,486
| +268% | +$6.55M |
|
816
Thor Industries
THO
$4.14B
| $9.21M | 0.02% |
122,588
-49,773
| -29% | -$3.83M |
|
817
PVH
PVH
$3.62B
| $9.13M | 0.02% |
122,943
+57,742
| +89% | +$4.94M |
|
818
Edwards Lifesciences
EW
$51.8B
| $9.07M | 0.02% |
100,271
-129,556
| -56% | -$10.9M |
|
819
SharkNinja
SN
$25.5B
| $9.06M | 0.02% |
59,517
-9,484
| -14% | -$1.14M |
|
820
Constellation Energy
CEG
$96.7B
| $9.02M | 0.02% |
36,302
-22,898
| -39% | -$6.45M |
|
821
Viking Therapeutics
VKTX
$3.95B
| $9M | 0.02% |
230,737
-30,041
| -12% | -$970K |
|
822
Invesco S&P MidCap Quality ETF
XMHQ
$5.66B
| $8.97M | 0.02% |
79,486
+12,469
| +19% | +$1.36M |
|
823
AppFolio
APPF
$7.95B
| $8.97M | 0.02% |
55,947
+37,798
| +208% | +$6.04M |
|
824
Vanguard High Dividend Yield ETF
VYM
$83.2B
| $8.96M | 0.02% |
56,720
+2,234
| +4% | +$349K |
|
825
State Street Energy Select Sector SPDR ETF
XLE
$41.7B
| $8.91M | 0.02% |
167,707
+64,288
| +62% | +$3.68M |
|
Similar funds
Joel Greenblatt's Q2 2026 Portfolio in Review
As of Q2 2026, Joel Greenblatt held 1,921 positions worth $43B, up 32% from $32.7B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Joel Greenblatt deployed $5.85B of net new capital in Q2 2026, opening 172 new positions and adding to 854 existing holdings. Its largest new stake was On Holding: 754,800 shares worth $26.7M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Western Digital, an estimated $97.7M trimmed.
- Joel Greenblatt's largest Q2 2026 buy was On Holding: 754,800 shares worth $26.7M.
- Joel Greenblatt added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $1.73B increase.
- Joel Greenblatt's biggest Q2 2026 reduction was Western Digital, cutting an estimated $97.7M.
- Joel Greenblatt fully exited Masimo in Q2 2026, selling an estimated $60.7M.
- Joel Greenblatt's ten largest holdings make up 28% of its $43B portfolio in Q2 2026.
- Joel Greenblatt opened 172 new positions and closed 130 in Q2 2026.
- Joel Greenblatt's portfolio value rose 32% quarter-over-quarter to $43B.
Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.